Skip to main content
Erschienen in: Medical Molecular Morphology 4/2014

01.12.2014 | Original Paper

Renal atrophy after ischemia–reperfusion injury depends on massive tubular apoptosis induced by TNFα in the later phase

verfasst von: Takaomi Adachi, Noriyuki Sugiyama, Hideo Yagita, Takahiko Yokoyama

Erschienen in: Medical Molecular Morphology | Ausgabe 4/2014

Einloggen, um Zugang zu erhalten

Abstract

Recent studies have suggested that acute kidney injury (AKI) develops into chronic kidney disease (CKD). However, a mechanism for disease progression from AKI to CKD has not been established. We developed two ischemia–reperfusion injury (IRI) mouse models, a repaired kidney model and an atrophic kidney model, and studied the mechanisms of renal atrophy after IRI by comparing the two models. We found that renal atrophy after IRI depended on tubular apoptosis at 14 days after IRI. Moreover, we found that Tnfα and FasL mRNA were synchronously expressed at the time of tubular apoptosis. To elucidate the relationship between tubular apoptosis and apoptotic ligands, we administered TNFα and FasL neutralizing antibodies according to the time of tubular apoptosis. TNFα blockade significantly repressed tubular apoptosis, resulting in the prevention of renal atrophy. FasL blockade could not repress tubular apoptosis, resulting in renal atrophy. We also found that TNF receptors were expressed in the kidney at 14 days after IRI, but Fas receptor was not. We concluded that renal atrophy after IRI depends on tubular apoptosis induced by the TNFα signaling pathway in the later phase of renal IRI, and that TNFα blockade could be a potential new therapeutic approach for improving renal prognosis after AKI.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Himmelfarb J, Ikizler TA (2007) Acute kidney injury: changing lexicography, definitions, and epidemiology. Kidney Int 71(10):971–976PubMedCrossRef Himmelfarb J, Ikizler TA (2007) Acute kidney injury: changing lexicography, definitions, and epidemiology. Kidney Int 71(10):971–976PubMedCrossRef
2.
Zurück zum Zitat Xue JL, Daniels F, Star RA, Kimmel PL, Eggers PW, Molitoris BA, Himmelfarb J, Collins AJ (2006) Incidence and mortality of acute renal failure in medicare beneficiaries, 1992 to 2001. J Am Soc Nephrol 17:1135–1142PubMedCrossRef Xue JL, Daniels F, Star RA, Kimmel PL, Eggers PW, Molitoris BA, Himmelfarb J, Collins AJ (2006) Incidence and mortality of acute renal failure in medicare beneficiaries, 1992 to 2001. J Am Soc Nephrol 17:1135–1142PubMedCrossRef
3.
Zurück zum Zitat Coca SG, Yusuf B, Shlipak MG, Garg AX, Parikh CR (2009) Long-term risk of mortality and other adverse outcomes after acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis 53:961–973PubMedCentralPubMedCrossRef Coca SG, Yusuf B, Shlipak MG, Garg AX, Parikh CR (2009) Long-term risk of mortality and other adverse outcomes after acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis 53:961–973PubMedCentralPubMedCrossRef
4.
Zurück zum Zitat Lo LJ, Go AS, Chertow GM, McCulloch CE, Fan D, Ordonez JD, Hsu CY (2009) Dialysis-requiring acute renal failure increases the risk of progressive chronic kidney disease. Kidney Int 76:893–899PubMedCentralPubMedCrossRef Lo LJ, Go AS, Chertow GM, McCulloch CE, Fan D, Ordonez JD, Hsu CY (2009) Dialysis-requiring acute renal failure increases the risk of progressive chronic kidney disease. Kidney Int 76:893–899PubMedCentralPubMedCrossRef
5.
Zurück zum Zitat Chawla LS, Amdur RL, Amodeo S, Kimmel PL, Palant CE (2011) The severity of acute kidney injury predicts progression to chronic kidney disease. Kidney Int 79:1361–1369PubMedCentralPubMedCrossRef Chawla LS, Amdur RL, Amodeo S, Kimmel PL, Palant CE (2011) The severity of acute kidney injury predicts progression to chronic kidney disease. Kidney Int 79:1361–1369PubMedCentralPubMedCrossRef
6.
Zurück zum Zitat Finn WF (1980) Enhanced recovery from postischemic acute renal failure. Micropuncture studies in the rat. Circ Res 46:440–448PubMedCrossRef Finn WF (1980) Enhanced recovery from postischemic acute renal failure. Micropuncture studies in the rat. Circ Res 46:440–448PubMedCrossRef
7.
Zurück zum Zitat Perico N, Cattaneo D, Sayegh MH, Remuzzi G (2004) Delayed graft function in kidney transplantation. Lancet 364:1814–1827PubMedCrossRef Perico N, Cattaneo D, Sayegh MH, Remuzzi G (2004) Delayed graft function in kidney transplantation. Lancet 364:1814–1827PubMedCrossRef
8.
Zurück zum Zitat Linkermann A, Brasen JH, Himmerkus N, Liu S, Huber TB, Kunzendorf U, Krautwald S (2012) Rip1 (receptor-interacting protein kinase 1) mediates necroptosis and contributes to renal ischemia/reperfusion injury. Kidney Int 81:751–761PubMedCrossRef Linkermann A, Brasen JH, Himmerkus N, Liu S, Huber TB, Kunzendorf U, Krautwald S (2012) Rip1 (receptor-interacting protein kinase 1) mediates necroptosis and contributes to renal ischemia/reperfusion injury. Kidney Int 81:751–761PubMedCrossRef
10.
Zurück zum Zitat Bonegio R, Lieberthal W (2002) Role of apoptosis in the pathogenesis of acute renal failure. Curr Opin Nephrol Hypertens 11:301–308PubMedCrossRef Bonegio R, Lieberthal W (2002) Role of apoptosis in the pathogenesis of acute renal failure. Curr Opin Nephrol Hypertens 11:301–308PubMedCrossRef
11.
Zurück zum Zitat Ortiz A, Justo P, Sanz A, Lorz C, Egido J (2003) Targeting apoptosis in acute tubular injury. Biochem Pharmacol 66:1589–1594PubMedCrossRef Ortiz A, Justo P, Sanz A, Lorz C, Egido J (2003) Targeting apoptosis in acute tubular injury. Biochem Pharmacol 66:1589–1594PubMedCrossRef
12.
Zurück zum Zitat Saikumar P, Venkatachalam MA (2003) Role of apoptosis in hypoxic/ischemic damage in the kidney. Semin Nephrol 23:511–521PubMedCrossRef Saikumar P, Venkatachalam MA (2003) Role of apoptosis in hypoxic/ischemic damage in the kidney. Semin Nephrol 23:511–521PubMedCrossRef
13.
Zurück zum Zitat Donnahoo KK, Meng X, Ao L, Ayala A, Shames BD, Cain MP, Harken AH, Meldrum DR (2001) Differential cellular immunolocalization of renal tumour necrosis factor-alpha production during ischaemia versus endotoxemia. Immunology 102:53–58PubMedCentralPubMedCrossRef Donnahoo KK, Meng X, Ao L, Ayala A, Shames BD, Cain MP, Harken AH, Meldrum DR (2001) Differential cellular immunolocalization of renal tumour necrosis factor-alpha production during ischaemia versus endotoxemia. Immunology 102:53–58PubMedCentralPubMedCrossRef
14.
Zurück zum Zitat Daemen MA, van de Ven MW, Heineman E, Buurman WA (1999) Involvement of endogenous interleukin-10 and tumor necrosis factor-alpha in renal ischemia–reperfusion injury. Transplantation 67:792–800PubMedCrossRef Daemen MA, van de Ven MW, Heineman E, Buurman WA (1999) Involvement of endogenous interleukin-10 and tumor necrosis factor-alpha in renal ischemia–reperfusion injury. Transplantation 67:792–800PubMedCrossRef
15.
Zurück zum Zitat Nogae S, Miyazaki M, Kobayashi N, Saito T, Abe K, Saito H, Nakane PK, Nakanishi Y, Koji T (1998) Induction of apoptosis in ischemia–reperfusion model of mouse kidney: possible involvement of fas. J Am Soc Nephrol 9:620–631PubMed Nogae S, Miyazaki M, Kobayashi N, Saito T, Abe K, Saito H, Nakane PK, Nakanishi Y, Koji T (1998) Induction of apoptosis in ischemia–reperfusion model of mouse kidney: possible involvement of fas. J Am Soc Nephrol 9:620–631PubMed
16.
Zurück zum Zitat Hamar P, Song E, Kokeny G, Chen A, Ouyang N, Lieberman J (2004) Small interfering rna targeting fas protects mice against renal ischemia–reperfusion injury. Proc Natl Acad Sci USA 101:14883–14888PubMedCentralPubMedCrossRef Hamar P, Song E, Kokeny G, Chen A, Ouyang N, Lieberman J (2004) Small interfering rna targeting fas protects mice against renal ischemia–reperfusion injury. Proc Natl Acad Sci USA 101:14883–14888PubMedCentralPubMedCrossRef
17.
Zurück zum Zitat Du C, Wang S, Diao H, Guan Q, Zhong R, Jevnikar AM (2006) Increasing resistance of tubular epithelial cells to apoptosis by shrna therapy ameliorates renal ischemia–reperfusion injury. Am J Transpl 6:2256–2267CrossRef Du C, Wang S, Diao H, Guan Q, Zhong R, Jevnikar AM (2006) Increasing resistance of tubular epithelial cells to apoptosis by shrna therapy ameliorates renal ischemia–reperfusion injury. Am J Transpl 6:2256–2267CrossRef
18.
Zurück zum Zitat Ko GJ, Jang HR, Huang Y, Womer KL, Liu M, Higbee E, Xiao Z, Yagita H, Racusen L, Hamad AR, Rabb H (2011) Blocking Fas ligand on leukocytes attenuates kidney ischemia–reperfusion injury. J Am Soc Nephrol 22:732–742PubMedCentralPubMedCrossRef Ko GJ, Jang HR, Huang Y, Womer KL, Liu M, Higbee E, Xiao Z, Yagita H, Racusen L, Hamad AR, Rabb H (2011) Blocking Fas ligand on leukocytes attenuates kidney ischemia–reperfusion injury. J Am Soc Nephrol 22:732–742PubMedCentralPubMedCrossRef
19.
Zurück zum Zitat Sugiyama N, Yokoyama T (2006) Sustained cell proliferation of renal epithelial cells in mice with inv mutation. Genes Cells 11:1213–1224PubMedCrossRef Sugiyama N, Yokoyama T (2006) Sustained cell proliferation of renal epithelial cells in mice with inv mutation. Genes Cells 11:1213–1224PubMedCrossRef
20.
Zurück zum Zitat Shimizu A, Yamanaka N (1993) Apoptosis and cell desquamation in repair process of ischemic tubular necrosis. Virchows Arch 64:171–180CrossRef Shimizu A, Yamanaka N (1993) Apoptosis and cell desquamation in repair process of ischemic tubular necrosis. Virchows Arch 64:171–180CrossRef
21.
Zurück zum Zitat Al-Lamki RS, Wang J, Skepper JN, Thiru S, Pober JS, Bradley JR (2001) Expression of tumor necrosis factor receptors in normal kidney and rejecting renal transplants. Lab Investig J Tech Methods Pathol 81:1503–1515CrossRef Al-Lamki RS, Wang J, Skepper JN, Thiru S, Pober JS, Bradley JR (2001) Expression of tumor necrosis factor receptors in normal kidney and rejecting renal transplants. Lab Investig J Tech Methods Pathol 81:1503–1515CrossRef
22.
Zurück zum Zitat Aten J, Roos A, Claessen N, Schilder-Tol EJ, Ten Berge IJ, Weening JJ (2000) Strong and selective glomerular localization of cd134 ligand and tnf receptor-1 in proliferative lupus nephritis. J Am Soc Nephrol 11:1426–1438PubMed Aten J, Roos A, Claessen N, Schilder-Tol EJ, Ten Berge IJ, Weening JJ (2000) Strong and selective glomerular localization of cd134 ligand and tnf receptor-1 in proliferative lupus nephritis. J Am Soc Nephrol 11:1426–1438PubMed
23.
Zurück zum Zitat Tsuruya K, Ninomiya T, Tokumoto M, Hirakawa M, Masutani K, Taniguchi M, Fukuda K, Kanai H, Kishihara K, Hirakata H, Iida M (2003) Direct involvement of the receptor-mediated apoptotic pathways in cisplatin-induced renal tubular cell death. Kidney Int 63:72–82PubMedCrossRef Tsuruya K, Ninomiya T, Tokumoto M, Hirakawa M, Masutani K, Taniguchi M, Fukuda K, Kanai H, Kishihara K, Hirakata H, Iida M (2003) Direct involvement of the receptor-mediated apoptotic pathways in cisplatin-induced renal tubular cell death. Kidney Int 63:72–82PubMedCrossRef
24.
Zurück zum Zitat Linkermann A, Himmerkus N, Rolver L, Keyser KA, Steen P, Brasen JH, Bleich M, Kunzendorf U, Krautwald S (2011) Renal tubular fas ligand mediates fratricide in cisplatin-induced acute kidney failure. Kidney Int 79:169–178PubMedCrossRef Linkermann A, Himmerkus N, Rolver L, Keyser KA, Steen P, Brasen JH, Bleich M, Kunzendorf U, Krautwald S (2011) Renal tubular fas ligand mediates fratricide in cisplatin-induced acute kidney failure. Kidney Int 79:169–178PubMedCrossRef
25.
Zurück zum Zitat Al-Lamki RS, Wang J, Vandenabeele P, Bradley JA, Thiru S, Luo D, Min W, Pober JS, Bradley JR (2005) Tnfr1- and tnfr2-mediated signaling pathways in human kidney are cell type-specific and differentially contribute to renal injury. Faseb J 19:1637–1645PubMedCrossRef Al-Lamki RS, Wang J, Vandenabeele P, Bradley JA, Thiru S, Luo D, Min W, Pober JS, Bradley JR (2005) Tnfr1- and tnfr2-mediated signaling pathways in human kidney are cell type-specific and differentially contribute to renal injury. Faseb J 19:1637–1645PubMedCrossRef
26.
Zurück zum Zitat Vielhauer V, Stavrakis G, Mayadas TN (2005) Renal cell-expressed tnf receptor 2, not receptor 1, is essential for the development of glomerulonephritis. J Clin Investig 115:1199–1209PubMedCentralPubMedCrossRef Vielhauer V, Stavrakis G, Mayadas TN (2005) Renal cell-expressed tnf receptor 2, not receptor 1, is essential for the development of glomerulonephritis. J Clin Investig 115:1199–1209PubMedCentralPubMedCrossRef
27.
Zurück zum Zitat Ramesh G, Reeves WB (2003) Tnfr2-mediated apoptosis and necrosis in cisplatin-induced acute renal failure. Am J Physiol 285:F610–F618 Ramesh G, Reeves WB (2003) Tnfr2-mediated apoptosis and necrosis in cisplatin-induced acute renal failure. Am J Physiol 285:F610–F618
28.
Zurück zum Zitat Guo G, Morrissey J, McCracken R, Tolley T, Klahr S (1999) Role of tnfr1 and tnfr2 receptors in tubulointerstitial fibrosis of obstructive nephropathy. Am J Physiol 277:F766–F772PubMed Guo G, Morrissey J, McCracken R, Tolley T, Klahr S (1999) Role of tnfr1 and tnfr2 receptors in tubulointerstitial fibrosis of obstructive nephropathy. Am J Physiol 277:F766–F772PubMed
29.
Zurück zum Zitat Fang L, Fang J, Chen CQ (2001) Tnf receptor-associated factor-2 binding site is involved in tnfr75-dependent enhancement of tnfr55-induced cell death. Cell Res 11:217–222PubMedCrossRef Fang L, Fang J, Chen CQ (2001) Tnf receptor-associated factor-2 binding site is involved in tnfr75-dependent enhancement of tnfr55-induced cell death. Cell Res 11:217–222PubMedCrossRef
30.
Zurück zum Zitat Misseri R, Meldrum DR, Dinarello CA, Dagher P, Hile KL, Rink RC, Meldrum KK (2005) Tnf-alpha mediates obstruction-induced renal tubular cell apoptosis and proapoptotic signaling. Am J Physiol 288:F406–F411 Misseri R, Meldrum DR, Dinarello CA, Dagher P, Hile KL, Rink RC, Meldrum KK (2005) Tnf-alpha mediates obstruction-induced renal tubular cell apoptosis and proapoptotic signaling. Am J Physiol 288:F406–F411
31.
Zurück zum Zitat Zhang X, Zheng X, Sun H, Feng B, Chen G, Vladau C, Li M, Chen D, Suzuki M, Min L, Liu W, Garcia B, Zhong R, Min WP (2006) Prevention of renal ischemic injury by silencing the expression of renal caspase 3 and caspase 8. Transplantation 82:1728–1732PubMedCrossRef Zhang X, Zheng X, Sun H, Feng B, Chen G, Vladau C, Li M, Chen D, Suzuki M, Min L, Liu W, Garcia B, Zhong R, Min WP (2006) Prevention of renal ischemic injury by silencing the expression of renal caspase 3 and caspase 8. Transplantation 82:1728–1732PubMedCrossRef
32.
Zurück zum Zitat Hotta K, Sho M, Yamato I, Shimada K, Harada H, Akahori T, Nakamura S, Konishi N, Yagita H, Nonomura K, Nakajima Y (2011) Direct targeting of fibroblast growth factor-inducible 14 protein protects against renal ischemia reperfusion injury. Kidney Int 79:179–188PubMedCrossRef Hotta K, Sho M, Yamato I, Shimada K, Harada H, Akahori T, Nakamura S, Konishi N, Yagita H, Nonomura K, Nakajima Y (2011) Direct targeting of fibroblast growth factor-inducible 14 protein protects against renal ischemia reperfusion injury. Kidney Int 79:179–188PubMedCrossRef
33.
Zurück zum Zitat Conlon PJ, Stafford-Smith M, White WD, Newman MF, King S, Winn MP, Landolfo K (1999) Acute renal failure following cardiac surgery. Nephrol Dial Transpl 14:1158–1162CrossRef Conlon PJ, Stafford-Smith M, White WD, Newman MF, King S, Winn MP, Landolfo K (1999) Acute renal failure following cardiac surgery. Nephrol Dial Transpl 14:1158–1162CrossRef
34.
Zurück zum Zitat Gwinner W, Hinzmann K, Erdbruegger U, Scheffner I, Broecker V, Vaske B, Kreipe H, Haller H, Schwarz A, Mengel M (2008) Acute tubular injury in protocol biopsies of renal grafts: prevalence, associated factors and effect on long-term function. Am J Transpl 8:1684–1693CrossRef Gwinner W, Hinzmann K, Erdbruegger U, Scheffner I, Broecker V, Vaske B, Kreipe H, Haller H, Schwarz A, Mengel M (2008) Acute tubular injury in protocol biopsies of renal grafts: prevalence, associated factors and effect on long-term function. Am J Transpl 8:1684–1693CrossRef
35.
Zurück zum Zitat Siew ED, Peterson JF, Eden SK, Hung AM, Speroff T, Ikizler TA, Matheny ME (2012) Outpatient nephrology referral rates after acute kidney injury. J Am Soc Nephrol 23:305–312PubMedCentralPubMedCrossRef Siew ED, Peterson JF, Eden SK, Hung AM, Speroff T, Ikizler TA, Matheny ME (2012) Outpatient nephrology referral rates after acute kidney injury. J Am Soc Nephrol 23:305–312PubMedCentralPubMedCrossRef
36.
Zurück zum Zitat Silva LC, Ortigosa LC, Benard G (2010) Anti-TNF-α agents in the treatment of immune-mediated inflammatory diseases: mechanisms of action and pitfalls. Immunotherapy 2(6):817–833PubMedCrossRef Silva LC, Ortigosa LC, Benard G (2010) Anti-TNF-α agents in the treatment of immune-mediated inflammatory diseases: mechanisms of action and pitfalls. Immunotherapy 2(6):817–833PubMedCrossRef
37.
Zurück zum Zitat Gómez-Reino JJ, Carmona L, Valverde VR, Mola EM, Montero MD, BIOBADASER Group (2003) Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report. Arthritis Rheum 48(8):2122–2127PubMedCrossRef Gómez-Reino JJ, Carmona L, Valverde VR, Mola EM, Montero MD, BIOBADASER Group (2003) Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report. Arthritis Rheum 48(8):2122–2127PubMedCrossRef
Metadaten
Titel
Renal atrophy after ischemia–reperfusion injury depends on massive tubular apoptosis induced by TNFα in the later phase
verfasst von
Takaomi Adachi
Noriyuki Sugiyama
Hideo Yagita
Takahiko Yokoyama
Publikationsdatum
01.12.2014
Verlag
Springer Japan
Erschienen in
Medical Molecular Morphology / Ausgabe 4/2014
Print ISSN: 1860-1480
Elektronische ISSN: 1860-1499
DOI
https://doi.org/10.1007/s00795-013-0067-3

Weitere Artikel der Ausgabe 4/2014

Medical Molecular Morphology 4/2014 Zur Ausgabe

Neu im Fachgebiet Pathologie